Clinical Trials · NCT02409849

Octreotide LAR as Maintenance Treatment for Patients With NEC

Name: Octreotide LAR as Maintenance Treatment for Patients With NEC
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 2Octreotide

Phase: Phase 2
Recruitment status: Unknown
Sponsor: Peking University
Enrollment: 92
Start date: Apr 2015
Locations: 1 site, China
Primary endpoint: PFS

View Octreotide compound reference